MIGUEL TIRADO: Open Payments
NPI 1922072313 · STATEN ISLAND, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,737 in 126 payments from 24 companies in 2025. Trend: 2023 $3,383 · 2024 $2,672 · 2025 $2,737
Food & beverage: $2,737
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 27 | $644 |
| Novo Nordisk Inc | 14 | $409 |
| Bayer Healthcare Pharmaceuticals Inc. | 14 | $229 |
| AstraZeneca Pharmaceuticals LP | 11 | $188 |
| PFIZER INC. | 8 | $176 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 9 | $140 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $108 |
| Inspire Medical Systems, Inc. | 2 | $104 |
| GlaxoSmithKline, LLC. | 5 | $101 |
| Otsuka America Pharmaceutical, Inc. | 5 | $94 |
Products named: VRAYLAR, Wegovy, Kerendia, CAPLYTA, REXULTI, Rybelsus, UBRELVY, BREZTRI.
Industry payments across NY — which companies pay providers there.
